Endoscope Reprocessing Market

The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027. The growth of this market is driven owing to iIncreasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during the forecast period. The Asia Pacific market is estimated to be the fastest-growing regional market, mainly due to the rising prevalence of target diseases, developing healthcare infrastructure, the availability of insurance coverage for endoscopy, and the growing medical tourism industry in Asia Pacific countries like China and India.

The endoscope reprocessing market is highly competitive in nature, with only a few players dominating the overall market. The major players operating in this market are Cantel Medical (US), Advanced Sterilization Products (ASP) (US), Olympus Corporation (Japan), Ecolab (US), STERIS (Ireland), Getinge AB (Sweden), Wassenburg Medical (Netherlands), CONMED Corporation (US), Belimed AG (Switzerland), Endo-Technik W. Griesat (Germany), Custom Ultrasonics (US), Steelco S.p.A. (Italy), BES Healthcare Ltd (UK), ARC Healthcare Solutions (Canada), Metrex Research, LLC. (Canada), Richard Wolf GmbH (Germany), MEDALKAN (Greece), Micro-Scientific, LLC (US), Borer Chemie AG (Switzerland), Tuttnauer (Netherlands), ATMS (Canada), Summit Imaging, Inc. (US), Medonica Co. LTD (South Korea), SHINVA MEDICAL INSTRUMENT CO. LTD (China), and Medical Devices Group Srl (Italy).

To know about the assumptions considered for the study download the pdf brochure

STERIS  (Ireland)

STERIS is the leading player in the endoscope reprocessing market, accounted for largest share in 2021. STERIS is a leading company in the infection control industry and is a leading provider of endoscope reprocessing products & solutions. The company’s broad product portfolio is its key strength. STERIS markets an array of products in the endoscope reprocessing market, broadly categorized as Manual Cleaning, VERIFY RESI-TEST Cleaning Indicators, High Level Disinfection, Liquid chemical sterilization, Endoscope Drying, Storage and Transport, and Endoscope Point of Use Pre-Cleaning. The company has manufacturing facilities or sales offices in North America, Europe, Asia, Australia, South America, and Africa. The company’s major sales are generated in the US, with no other country accounting for more than 10% of consolidated sales revenue. Ireland’s revenue showed a 12.4% increase over 2019 revenues, followed by the US with 11.9%, and the other foreign locations with 0.9% growth. This increase in revenue was reflected by subsequent growth in the Canadian and Latin American regions. Europe and the Middle East & Africa reported slight declines, primarily due to actions taken in conjunction with STERIS ’s 2019 Restructuring Planportfolio with the surgical asset management and instrument tracking solutions from Censis. These activities have helped the company gain a strong foothold in the market.

Advanced Sterilization Products (US)

Advanced Sterilization Products held the second-largest share of the endoscope reprocessing market in 2021. The company offers endoscope reprocessing products which include Automatic Endoscope Reprocessors (AER), detergents, and Biocides/HLD. Advanced Sterilization Products has strong presence Globally, including the North America, Europe, and the Asia Pacific region,  which made the firm garner a larger market share. This enables the company to cater to a larger customer base and hence increase its revenue significantly.

Olympus Corporation (Japan)

a Olympus Corporation held the third position in the endoscope reprocessing market in 2021. The company has a dedicated business segment which focuses on solutions offered in endoscopy, named Endoscopic Solutions Business. The company has emphasized enhancing its offering to improve the efficiency of its reprocessing systems. In 2018, About USD 0.4 Bn (i.e., 4.0 billion) was invested by Olympus to enhance their systems for performing tests to check cleaning and disinfection effectiveness. By this initiative, the company focus to develop systems that would help the company to swiftly respond to the requirements and major issues faced worldwide due to reprocessing. These advancements enable the company i to account a strong position in the market.

Related Reports:

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) - Global Forecast to 2027

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]